What is Kynectiv?
Kynectiv is recognized as a leading provider of simulation-based technology, serving global audiences with its DecisionSim platform. This innovative solution empowers organizations to enhance their training programs by fostering increased engagement, improving knowledge retention, and facilitating comprehensive data collection for actionable insights. The company boasts a seasoned team of instructional designers, technologists, and data scientists dedicated to maximizing the benefits derived from their simulation platform. Kynectiv's simulation technology has garnered adoption among prominent healthcare entities, including the Department of Veterans Affairs (VA), pharmaceutical firms, medical societies, educational providers, and academic institutions. To date, Kynectiv simulations have facilitated over 200,000 sessions, with nearly 5 million decisions recorded.
How much funding has Kynectiv raised?
Kynectiv has raised a total of $1.9M across 1 funding round:
Series A
$1.9M
Series A (2015): $1.9M with participation from Rittenhouse Ventures and Ben Franklin Technology Partners of Southeastern Pennsylvania
Key Investors in Kynectiv
Rittenhouse Ventures
Rittenhouse Ventures is a Philadelphia-based venture capital firm specializing in early-stage investments in technology businesses. They provide tailored investments, strategic support, and expertise to drive successful financial outcomes, with a portfolio that includes companies in healthcare technology and patient engagement.
Ben Franklin Technology Partners of Southeastern Pennsylvania
Ben Franklin Technology Partners of Southeastern Pennsylvania is a state-funded initiative that provides seed funding, technical assistance, and business support services to technology-based startups and established companies in the region. They focus on fostering innovation and economic growth through strategic investments in promising ventures.
What's next for Kynectiv?
The substantial enterprise-level funding Kynectiv has achieved, particularly the recent major strategic investment, signals a strong validation of its DecisionSim platform and its market traction. This capital infusion is likely to fuel further development of its simulation technology, expansion into new markets, and enhancement of its data analytics capabilities. Kynectiv's focus on healthcare and its proven track record with significant institutions suggest a strategic direction towards deepening its penetration in this critical sector, potentially through further product innovation and strategic partnerships. The company's trajectory indicates a move towards scaling its operations and solidifying its leadership in the simulation-based training and decision-making technology space.
See full Kynectiv company page
